/PRNewswire/ BiologicsMD, a preclinical therapeutic development company focused on highly-targeted treatments for hair loss and bone disorders, announced.
/PRNewswire/ Avanos Medical, Inc. (NYSE: AVNS) today announced it has entered into a definitive agreement to acquire OrthogenRx, Inc., an emerging leader in.